DDW: No New Leukoencephalopathy Cases Seen With Natalizumab (Tysabri)
MedPage Today - Little Falls,NJ,USA
By John Gever, Staff Writer, MedPage Today SAN DIEGO, May 18 -- Patients treated with natalizumab (Tysabri) for multiple sclerosis or Crohn's disease since ...
See all stories on this topic

DDW: No New Leukoencephalopathy Cases Seen With Natalizumab (Tysabri)
SAN DIEGO -- Patients treated with natalizumab (Tysabri) for multiple sclerosis or Crohn’s disease since it returned to the U.S. market two years ago have been free of progressive multifocal leukoencephalopathy (PML), according to one of the drug’s sponsors. full story

http://www.medpagetoday.com/MeetingCoverage/DDW/tb/9516

FDA Issues Second CellCept Warning
Newsinferno.com - New York,NY,USA
Progressive multi-focal leukoencephalopathy is associated with at least one other drug, Tysabri, which is used to treat multiple sclerosis. ...
See all stories on this topic

Neural cell transplants may be potential therapy for Parkinson’s ...
Thaindian.com - Bangkok,Bangkok,Thailand
In one study, the ability of transplantation of human neural progenitor cells (hNPCs) to produce glial derived neurotrophic factor (GDNF) in the brain was ...
See all stories on this topic

Neural cell transplants may help those with Parkinson's disease
EurekAlert (press release) - Washington,DC,USA
... (hNPCs) as a potential therapy when hNPCs were engineered to produce glial derived neurotrophic factor (GDNF) in the brain following hNPC transplants. ...
See all stories on this topic

Immune Cells Kill Foes By Disrupting Mitochondria 2 Ways
When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. A new study shows T cells can initiate cellular suicide, also known as programmed cell death or apoptosis, by a previously unrecognized pathway that starts with the destruction of a key enzyme in mitochondria, the power plant of the cell.

Big Brother star in charity zipslide plunge
ChronicleLive - Newcastle upon Tyne,England,UK
Patsy, now 15, a pupil at Gateshead’s Thomas Hepburn School, became the only person under 18 to try out the trial MS drug Campath. ...
See all stories on this topic

MPs vote on embryo research
stv.tv - UK
Sue Polson has suffered from Multiple Sclerosis for the past 11 years. She says its crucial MPs do not stand in the way of scientific research into ...
See all stories on this topic

Antibodies in the brain
PhysOrg.com - Evergreen,VA,USA
However, sometimes these antibodies go haywire and attack structures of their own body, for example nerve cells in patients with multiple sclerosis. ...
See all stories on this topic

Embryology Bill: Open Letter to MPs
Telegraph.co.uk - United Kingdom
The overwhelming majority of those affected by conditions such as Parkinson's, Alzheimer's, motor neurone disease, multiple sclerosis, diabetes, ...
See all stories on this topic

Creating Stem Cells
Ivanhoe - Winter Park,FL,USA
Sundari Mani of the Weinberg lab in Cambridge, Mass. worked on the study with colleagues from Boston’s Brigham and Women’s Hospital, the University of ...
See all stories on this topic

Reported May 22, 2008

Ivanhoe's Medical Breakthroughs - Taking Care of Caregivers

TAMPA, Fla. (Ivanhoe Newswire) -- Clinical trials are generally for a patient, not the people taking care of the patient; but a new study focuses on the caregiver and how support can help everyone involved.

Louise Jolliff is the ultimate caregiver. For 40 years, she has taken care of her son, Jerry, who has cerebral palsy and for the last five years, she has been caring for her husband, Wade, who has prostate cancer. "Without her, I think I would probably not make it, but with her, I can do anything," Wade says. "Care giving is very hard because everybody says, 'You've gotta take care of yourself,'" Louise told Ivanhoe. "That sounds very good, but it's very difficult to do."

More than 50 million people in the United States are caregivers. Their help saves the health care system more than $300 billion a year. That's why a new clinical trial focuses on educating the caregiver. Study project manager Darlene Johnson is passionate about this research because she is a tongue cancer survivor. Her husband was her caregiver. "I went home and told him about the study, and he said, 'Ah, man. I wish I had something like that when you were going through this,' because he felt very insecure himself," Johnson of the Moffitt Cancer Center in Tampa, Fla., told Ivanhoe.

For the study, caregivers will have one-on-one time with a nurse and receive a home care guide book. Some of the advice: 1) take time to rest -- devote at least 30 minutes a day to yourself; 2) Be open in your conversations with the patient -- talk about life and death; 3) Watch for signs of depression and 4) Let the sick person make as many decisions as possible.

"I think this training will be invaluable," Johnson says. "Whatever you don't understand, you can ask a lot of questions," Louise adds. Louise also says she does one thing to help her get through each day: "I do a lot of praying, and that gives me strength."

The study at Moffitt Cancer Center is open to patients and their caregivers for the next year. To qualify for the trial, patients must be older than 70 years of age and have a diagnosis of colon cancer or non-Hodgkin's lymphoma.

Sign up for a free weekly e-mail on Medical Breakthroughs called First to Know by clicking here.

FOR MORE INFORMATION, PLEASE CONTACT:

Moffitt Cancer Center and Research Institute

Tampa, FL

(813) 745-3822

http://www.moffitt.org

http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=18678

regenerative medicine

GMS Dental Centers of Excellence & StemSave Offer Houstonians the ...
Earthtimes (press release) - London,UK
... into treatments for a wide range of diseases, including Parkinson’s disease, heart disease, diabetes, arthritis, osteoporosis and multiple sclerosis. ...
See all stories on this topic

multiple sclerosis stem cells

Invitrogen Launches Cell Therapy Unit
GenomeWeb News (subscription) - NY,USA
... specific needs of cell therapy companies,” said Joydeep Goswami, Invitrogen’s vice president of stem cells and regenerative medicine, in a statement. ...
See all stories on this topic

Invitrogen, Becton Dickinson, Cytopeia, National Institutes of ...
Cell Based Assay News (subscription) - New York,NY,USA
It said the Influx could be used in cell therapy research, stem cell research, drug discovery and development, and marine biology applications and is ...
See all stories on this topic

Nanotech Stem Cells, Order Now!
Corante - Boston,MA,USA
Stem cells and nanostructures are two undeniably hot areas of research. And also undeniable is that fact that they're both in their very early days - the ...
See all stories on this topic